Literature DB >> 11912357

Endothelin 1 levels in the aqueous humor of dogs with glaucoma.

Maria E Källberg1, Dennis E Brooks, Gustavo A Garcia-Sanchez, Andras M Komàromy, Nancy J Szabo, Lili Tian.   

Abstract

PURPOSE: Endothelin 1 is a small peptide that is involved in regulation of intraocular pressure and modulation of ocular circulation. To investigate the role of endothelin 1 in canine glaucoma, the authors measured aqueous humor levels of endothelin 1 in healthy dogs and in dogs with hypertensive glaucoma.
METHODS: Aqueous humor samples were obtained with general anesthesia from the eyes of healthy dogs (n = 5) and dogs with hypertensive glaucoma (n = 10). Measurements were made by enzyme immunoassay for endothelin 1.
RESULTS: The endothelin 1 aqueous humor range was 1.12 - 3.63 pg/mL for healthy dogs and 1.97 - 14.97 pg/mL for glaucomatous dogs. The healthy and glaucomatous canine endothelin 1 aqueous levels (mean +/- SD) were 2.33 +/- 0.90 and 8.11 +/- 5.03 pg/mL, respectively. A two-way analysis of variance indicated that this difference was significant (P = 0.0084). The effect of age on endothelin 1 levels was not significant (P = 0.6283). The large variability found within the glaucomatous group could be explained by the degree of damage of the retina (P = 0.0006). There was no significant correlation between intraocular pressure and endothelin 1 aqueous humor levels within the glaucomatous group (P = 0.29).
CONCLUSIONS: The aqueous humor of dogs with hypertensive glaucoma contains significantly higher levels of endothelin 1 than that of healthy dogs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11912357     DOI: 10.1097/00061198-200204000-00005

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  16 in total

1.  Increased plasma endothelin-1 levels in patients with progressive open angle glaucoma.

Authors:  M Emre; S Orgül; T Haufschild; S G Shaw; J Flammer
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

Review 2.  Endothelin antagonism as an active principle for glaucoma therapy.

Authors:  Rita Rosenthal; Michael Fromm
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

3.  Endothelin-Mediated Changes in Gene Expression in Isolated Purified Rat Retinal Ganglion Cells.

Authors:  Shaoqing He; Yong H Park; Thomas Yorio; Raghu R Krishnamoorthy
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-09-01       Impact factor: 4.799

Review 4.  Targets of Neuroprotection in Glaucoma.

Authors:  Shaoqing He; Dorota L Stankowska; Dorette Z Ellis; Raghu R Krishnamoorthy; Thomas Yorio
Journal:  J Ocul Pharmacol Ther       Date:  2017-08-18       Impact factor: 2.671

Review 5.  Endothelin, astrocytes and glaucoma.

Authors:  Ganesh Prasanna; Raghu Krishnamoorthy; Thomas Yorio
Journal:  Exp Eye Res       Date:  2010-09-16       Impact factor: 3.467

6.  Dexamethasone induces cross-linked actin networks in trabecular meshwork cells through noncanonical wnt signaling.

Authors:  Yong Yuan; Mindy K Call; Yan Yuan; Yujin Zhang; Katy Fischesser; Chia-Yang Liu; Winston W-Y Kao
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-10-03       Impact factor: 4.799

7.  Endothelin-1 mediated regulation of extracellular matrix collagens in cells of human lamina cribrosa.

Authors:  Vidhya R Rao; Raghu R Krishnamoorthy; Thomas Yorio
Journal:  Exp Eye Res       Date:  2008-03-12       Impact factor: 3.467

Review 8.  Eyeing endothelins: a cellular perspective.

Authors:  Ganesh Prasanna; Santosh Narayan; Raghu R Krishnamoorthy; Thomas Yorio
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

9.  Concentration-related effects of nitric oxide and endothelin-1 on human trabecular meshwork cell contractility.

Authors:  W Michael Dismuke; Jin Liang; Darryl R Overby; W Daniel Stamer
Journal:  Exp Eye Res       Date:  2013-12-27       Impact factor: 3.467

10.  Endothelin B receptors contribute to retinal ganglion cell loss in a rat model of glaucoma.

Authors:  Alena Z Minton; Nitasha R Phatak; Dorota L Stankowska; Shaoqing He; Hai-Ying Ma; Brett H Mueller; Ming Jiang; Robert Luedtke; Shaohua Yang; Colby Brownlee; Raghu R Krishnamoorthy
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.